The role of Gal-3 as an independent predictor of outcomes in HF has not been confirmed; however, adding Gal-3 to the well-established NT-proBNP ameliorated the prediction of adverse outcomes [53], probably because the population of patients with higher Gal-3 were also the most-frail. The gene discussed is LGALS3; the disease is hydrops fetalis.